PSYCH Interview: Rick Doblin - Psychedelics Market Hype Published 2021-04-19 Download video MP4 360p Download video MP4 720p Recommendations 1:39:48 Psychedelics: Chemicals, Consciousness, and Creativity 1:01:10 Investigational MDMA-Assisted Therapy for PTSD:Phase 3 Data by Rick Doblin at ALPS Conference 2023 08:33 Where Psychedelic Medicines Are Headed with Rick Doblin, PhD - MAPS 21:40 What If You Ate 4 EGGS A Day With The YOLKS For 30 Days? 13:09 Face Your Dark Side, Become Your True Self - Jordan Peterson (Best Motivational Speech) 19:04 Rick Perry: The conservative case for psychedelic medicine 3:54:38 Optogenetics: Illuminating the Path toward Causal Neuroscience 16:17 Warren Buffett Leaves The Audience SPEECHLESS | One of the Most Inspiring Speeches Ever 16:48 Psychedelics & Cannabis (Rick Doblin Interview) 08:13 AstraZeneca Admits Vaccine Causes Rare Side Effects 28:03 PSYCH Symposium: Shifting Perceptions - in conversation with Professor Robin Carhart-Harris 08:34 I Tried Abundance Mindset for 1 Year: Heres What Happened 40:24 «4000 тижнів. Тайм менеджмент для смертних» | Олівер Беркмен 10:48 PSYCH Symposium: Understanding institutional investors’ interest in psychedelics 21:57 PSYCH Symposium: Ketamine assisted therapy to treat addiction 02:16 PSYCH Interview: Rick Doblin - Ensuring a Supply Chain of Trained Psychedelic Therapists 24:39 PSYCH Symposium: Reassessing the Psychedelic Space 04:16 Robbie The Cameraman Has A Weed Motorcycle | CONAN on TBS 21:17 ALCOHOLIC Interview Nason's Recovery Story - addiction and sobriety 28:07 PSYCH Symposium: Treating eating disorders Similar videos 42:08 PSYCH Interview: Rick Doblin MAPS Founder - The Future of Psychedelics Medicine and Industry 00:35 PSYCH Interview: Rick Doblin - Market Sizing and Health Care Coverage 01:26 PSYCH Interview: Rick Doblin - Licensed Psychedelic Legalization by 2035 01:26 PSYCH Interview: Rick Doblin - Drug Policy Reform Will Help Business 01:09 PSYCH Interview: Rick Doblin - Groundbreaking Phase 3 Study Results for PTSD with MDMA 00:39 PSYCH Interview: Rick Doblin - The Value of Non-Profits to For-Profit Psychedelics Companies 02:30 PSYCH Interview: Rick Doblin - Patents vs. Data Exclusivity 01:05 PSYCH Interview: Rick Doblin - Net Zero Trauma by 2050 00:50 PSYCH Interview: Rick Doblin - Is Telemedicine and the Psychedelic 'Take-Home' Method Effective? 02:02 PSYCH Interview: Rick Doblin - The Challenge to Retain Non-Profit Talent in a For-Profit Industry 03:06 PSYCH Interview: Rick Doblin - Investors Should Examine a Company's Cost Structure 01:18 PSYCH Interview: Rick Doblin - Psychedelic Patents and Shorter-Acting Molecules 48:05 The ‘hype and hope’ of psychedelic medicines exposed | Four Corners 11:43 Psychedelics Are Fueling a Mental Health Revolution 1:00:59 #48 Rick Doblin on MDMA and the Future of Psychedelic Therapy (:macro) 1:24:15 Psychedelic Research, Psilocybin Therapy and Mental Illness 1:00:01 Investing in New Frontiers of Health: AI, Psychedelics, the Gut-Brain Axis, and More! | SXSW 2024 15:00 Psychedelic Therapy With Psilocybin and MDMA: Basics + History (What Took So Long?) More results